IOPtima is dedicated to improving ophthalmic care through the development and commercialization of innovative products addressing a wide range of ocular conditions

Glaucoma
Oculoplasty
Ocular Surface Disorder
Experience the New

Our Products

IOPtimate®

Glaucoma Surgery

The IOPtimate® is a surgical system for treating glaucoma which utilizes CO2 laser technology to significantly reduce the intraocular pressure (IOP) by restoring the natural fluid percolation without penetrating the eye.

Learn More
ioptimate

iLid™

Oculoplasty – Skin Resurfacing

The iLid™ CO2 laser kit is a more precise alternative to manual surgical scalpels for oculoplasty Surgeons to incise the upper and/or lower eyelids and remove excess fat. The iLid™ also has a handpiece that can be used for skin resurfacing, resulting in younger-looking skin for patients.

Learn More
ilid

Lipitear™ Multi

Ocular Surface Disorder

Lipitear™ Multi is a unique, innovative, preservative-free, vegan lipid-based microemulsion formula for the relief of all common symptoms of ocular surface disorder such as dryness, irritation, grittiness, burning, and stinging.

Lipitear™ Multi, phospholipid microemulsion for ophthalmic use, is indicated for reducing dry eye symptoms.

Learn More
lipitear multi

Fabilas™

Glaucoma – Oculoplasty – Skin Resurfacing

Fabilas™ is a one-of-a-kind surgical platform that allows physicians to perform a variety of ocular treatments for different indications with high precision and safety.
‍Launching soon

Learn More
fabilas

Our Latest News

Read all news
Glaucoma - 5 Myths Debunked

Glaucoma - 5 Myths Debunked

Debunking myths and having the facts about glaucoma is essential to protect and preserve eye health.

How to Manage Dry Eye disease

How to Manage Dry Eye disease

July is Dry Eye Awareness Month, so IOPtima would like to present the first advertisements for the only preservative-free lipid-based eye drops, LIPITEAR™ MULTI, that are currently already available in Israel.

Announcing Eran Kaplan as new CEO of IOPtima

Announcing Eran Kaplan as new CEO of IOPtima

We’re pleased to announce that we have appointed Eran Kaplan as new Chief Executive Officer of IOPtima. Eran's appointment is a clear reflection of the company’s current state: ready to take on the future and fired up. IOPtima is poised for an innovation and expansion in the Laser based Ophthalmic market and we’re excited what Eran's unique experience in the field.

What the Experts Say

Prof. Ehud Assia

Meir Medical Center, Kfar Saba, Israel - Inventor

The eye is normally quiet and the patient's vision returns to normal soon after surgery. Fluid percolation is constantly assessed during surgery, and if needed, further laser ablations may be applied until a satisfactory clinical result is achieved. The CLASS learning curve is fast.

Take your clinic to the next level!
To schedule a demo, contact us.

Contact us

IOPtima is dedicated to improving ophthalmic care through the development and commercialization of innovative products for a wide range of ocular conditions.

IOPtima is a Chengdu Kanghong Pharmaceutical company.

Read More
Our Products
IOPtimate®Fabilas™iLid™Lipitear™
Treatments
GlaucomaEyelid SurgerySkin ResurfacingOcular Surface Disorder
Pitch an Idea

IOPtima, along with our parent company, Kanghong Pharmaceuticals, is working with companies, researchers and doctors around the world with a mission to bring the most advanced, safe and effective products to the ophthalmic community. We invite you to partner with us on this important mission. Contact us if you have an innovative product, idea or are looking to partner for the development or commercialization of your product.

Contact Us
Privacy • Terms • All Right Reserved 2022  • Made by BRACT Agency